Completed

Tryptophan and Behavior Therapy for Cocaine Abuse

What is being tested

Tryptophan

Drug

Who is being recruted

Mental Disorders+1

+ Substance-Related Disorders

+ Chemically-Induced Disorders

From 18 to 55 Years

+4 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 2

Interventional

Study Start: March 1997

See protocol details

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 12, 2017

Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 1997

Actual date on which the first participant was enrolled.

This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention model of treatment intervention.

NCT00000324

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 12, 2017

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersSubstance-Related DisordersChemically-Induced DisordersCocaine-Related Disorders

Criteria

1 inclusion criteria required to participate

Cocaine dependent

3 exclusion criteria prevent from participating

Physically dependent on drugs of abuse other than cocaine

Pregnant

Significant medical or psychiatric illness (besides substance abuse disorder)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Johns Hopkins University School of Medicine

Baltimore, United StatesOpen Johns Hopkins University School of Medicine in Google Maps

CompletedOne Study Center